EP0673559A1 - Motor system with individually controlled redundant windings - Google Patents
Motor system with individually controlled redundant windingsInfo
- Publication number
- EP0673559A1 EP0673559A1 EP94903543A EP94903543A EP0673559A1 EP 0673559 A1 EP0673559 A1 EP 0673559A1 EP 94903543 A EP94903543 A EP 94903543A EP 94903543 A EP94903543 A EP 94903543A EP 0673559 A1 EP0673559 A1 EP 0673559A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- windings
- motor
- winding
- synchronized
- control means
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02K—DYNAMO-ELECTRIC MACHINES
- H02K16/00—Machines with more than one rotor or stator
- H02K16/04—Machines with one rotor and two stators
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02K—DYNAMO-ELECTRIC MACHINES
- H02K29/00—Motors or generators having non-mechanical commutating devices, e.g. discharge tubes or semiconductor devices
- H02K29/06—Motors or generators having non-mechanical commutating devices, e.g. discharge tubes or semiconductor devices with position sensing devices
Definitions
- This invention relates generally to brushless DC motor systems.
- the invention relates to a brushless DC motor system especially adapted for use in high reliability uses where redundancy is essential, such as in thrust vector control of rocket engines.
- Thrust vector control of rocket engines has in the past been primarily accomplished with the use of hydraulic actuators.
- Hydraulic actuators employing hydraulic pumps while commonly in use, have a disadvantage in that they require high- maintenance costs and suffer from low reliability. More particularly, hydraulic pumps typically run at full speed thereby requiring operation of the hydraulic system controlling the rocket engine to operate at continuous maximum power. Other disadvantages include the fact that they require use of dangerous materials such as hydrazine and are generally very messy due to the presence of hydraulic fluid over the parts.
- Alternative approaches to hydraulic actuators have involved the use of electromagnetic actuators. In comparison to hydraulic systems, electromagnetic actuator systems use much less energy, with a typical hydraulic actuator system using over 34 times as much energy during a mission as a comparable electromagnetic actuator system.
- DC brushless motors are available in several configurations from open loop controlled multi-toothed propelled drives called stepping motors to inside permanent magnet rotor and outside permanent magnet rotor closed loop machines. Due to their wide range of performance and motion control capabilities, such motors are theoretically particularly desirable for use in applications such as rocket vector control, for example, in controlling the direction of orientation of rocket motor nozzles. However, such motors have not been used widely in the field of rocket nozzle control because in the event of shorting of the winding of the motor, the system could experience a catastrophic failure due to the inability to move the DC brushless motor, which locks up upon the shorting of a winding. As may be appreciated, such a failure in the motor can result in a complete and catastrophic failure of the rocket mission.
- the permanent magnet motor system includes a shaft for having multiple permanent magnets mounted thereon, and with the shaft rotatably mounted for rotation about a central axis thereof.
- the permanent magnets are mounted along a predetermined length of the shaft, substantially around the circumference thereof, for causing the shaft to rotate as a result of an inductive force being applied to the permanent magnets.
- At least three windings, each electrically isolated from each other, are arranged around the permanent magnets, each for being individually electrically excited to generate an induction field. The field generated causes the shaft to rotate as a result of the interaction between the generated field and the permanent magnets.
- Individual winding controllers for example, pulse width modulation controller chips, individually control each of the windings in a manner such that should there be a short in one of the windings, the other two windings continue to generate the necessary fields to (1) continue to drive the shaft in a rotational motion, and (2) overcome the drag created by the shorted winding.
- the motor system is fault tolerant taking into account, in a DC brushless motor arrangement, the possible shorting of a winding thereof.
- the windings are preferably arranged in a Y-winding configuration with each of the winding legs parallel to the others. Such a configuration is conventional and well known to those of ordinary skill in the art.
- the winding controllers are insulated gate bipolar transistor power modules.
- the windings comprise at least three windings and more preferably, at least eight. As may be appreciated, in the case with eight windings, should one winding short, the motor will still retain 3/4 of its power due to the loss of one winding by shorting, and another winding being dedicated to overcoming the drag of the winding that shorted. In the case of a single winding shorting in a three winding arrangement, 1/3 power is retained.
- a sensor or sensors are arranged for detecting the rotational position of the shaft.
- the sensor or sensors provide a signal to a motor controller, which controls the insulated gate bipolar transistor power modules of the windings, to issue a control signal to the power modules to excite the windings to cause the shaft to be rotated into a desired position.
- Figure 1 is a schematic diagram of the control circuit architecture and winding arrangement for a DC brushless motor system in accordance with the invention.
- Figure 2 is a second schematic diagram showing the control modules of Figure 1 connected to a motor controller, and with the motor shaft having a position sensor thereon.
- the fault tolerant winding control system in accordance with the invention, is designated generally by the reference number 1 1.
- a single common shaft 13 is shown illustrated in association with redundant windings 17 arranged in a Y configuration about the shaft.
- the shaft 13 includes permanent magnets
- the windings 17 are connected in a manner to be individually and separately electrically excited to generate a field which interacts with the magnets to cause the shaft 13 to rotate.
- Each winding 17 has three legs, 19a, 19b, and 19c, which are arranged in a conventional and well known Y configuration.
- each winding 17 is shown individually controlled by a respective control module 21.
- These modules 21 are, for example, insulated gate bipolar transistor power modules.
- the other redundant windings 17, which are each individually and separately controlled by the power modules 21 through insulated gate bipolar transistors 23a, 23b and 23c, continue to drive the shaft 13 of the motor.
- modules 21 they are conventional and well known to those of ordinary skill in the art. Examples of such commercially available modules include the PWR-82331 high current three-phase bridge power hybrid. Details of such a module are disclosed in the publication by ILC Data Device Corporation PWR-282331 Smart Power Three-Phase Bridge. 1989, which disclosure is incorporated by reference herein.
- a motor controller 27 is employed to control the power modules 21 such that they are synchronized to ensure that the magnets are acted upon by the fields generated by individual windings 17 in a synchronized manner.
- a motor controller 27 is employed.
- Such a controller 27 is conventional and well known and can take the form of, for example, a programmable logic array (PLA).
- PPA programmable logic array
- position sensors 29 can be mounted on the shaft 13 to detect the position of the shaft 13 relative to where it has been commanded by motor controller 27 to be located.
- the position detection sensors 29 provide a position signal to motor controller 27 wherein it is compared to a reference to result in an error signal.
- the error signal is then processed by the controller 27 to generate a signal to the control modules 21 to cause the shaft 19 to be rotated to the desired position correcting for the error until the error signal generated is equal to null.
Abstract
A fault tolerant brushless DC motor includes plural parallel windings (17), each individually controlled by a respective control module (21). At least three windings are provided such that in the event there is a short in one of the windings, the other two windings continue to generate a field to cause the shaft (13) of the motor, having permanent magnets (15) mounted thereon, to rotate. Preferably at least three windings (17) are provided such that in the event of a single short, one of the remaining two windings serves to nullify the drag generated by the shorted winding with the other remaining winding generating a sufficient field to cause the shaft (13) of the motor to rotate. The motor system has particular application in a field of vector control of rocket nozzles. In a preferred configuration, the system includes eight windings (17).
Description
MOTOR SYSTEM WITH INDIVIDUALLY CONTROLLED REDUNDANT WINDINGS
FIELD OF THE INVENTION This invention relates generally to brushless DC motor systems. In particular, the invention relates to a brushless DC motor system especially adapted for use in high reliability uses where redundancy is essential, such as in thrust vector control of rocket engines.
BACKGROUND OF THE INVENTION
Thrust vector control of rocket engines has in the past been primarily accomplished with the use of hydraulic actuators. Hydraulic actuators employing hydraulic pumps, while commonly in use, have a disadvantage in that they require high- maintenance costs and suffer from low reliability. More particularly, hydraulic pumps typically run at full speed thereby requiring operation of the hydraulic system controlling the rocket engine to operate at continuous maximum power. Other disadvantages include the fact that they require use of dangerous materials such as hydrazine and are generally very messy due to the presence of hydraulic fluid over the parts. Alternative approaches to hydraulic actuators have involved the use of electromagnetic actuators. In comparison to hydraulic systems, electromagnetic actuator systems use much less energy, with a typical hydraulic actuator system using over 34 times as much energy during a mission as a comparable electromagnetic actuator system. Other advantages resulting from the use of electromagnetic actuator systems is that they are very rugged and require low maintenance. Further, installation of such devices is extremely simple and testing of such systems can be accomplished prior to launch of a rocket using either external or internal battery power. In this regard, the past three basic approaches for motors in electromagnetic actuator systems used in rocket nozzle control have been considered. Specifically, the systems considered in the past are "switched reluctance", "AC induction" and "DC brushless motors".
DC brushless motors are available in several configurations from open loop controlled multi-toothed propelled drives called stepping motors to inside permanent magnet rotor and outside permanent magnet rotor closed loop machines. Due to their wide range of performance and motion control capabilities, such motors are theoretically particularly desirable for use in applications such as rocket vector control, for example, in controlling the direction of orientation of rocket motor nozzles. However, such motors have not been used widely in the field of rocket nozzle control because in the event of shorting of the winding of the motor, the system could
experience a catastrophic failure due to the inability to move the DC brushless motor, which locks up upon the shorting of a winding. As may be appreciated, such a failure in the motor can result in a complete and catastrophic failure of the rocket mission.
Thus, to date, as an alternative to the above noted hydraulic systems, there has been proposed the use of AC induction motors. Such systems are desirable in that AC induction motors will typically not lock up upon the shorting of a winding, but have the disadvantages that AC induction motor control electronics are highly complex and the torque/speed characteristics of such motors vary greatly and do not provide the precise control desired for rocket nozzles. Accordingly, in accordance with the invention, there is proposed a DC brushless motor system which suffers none of the disadvantages of hydraulic and AC motor systems while overcoming the previously recognized catastrophic failure possibilities. More particularly, there is disclosed herein a DC brushless motor system which is fault tolerant to windings shorting when in operation.
SUMMARY OF THE INVENTION In accordance with one aspect of the invention there is provided a permanent magnet motor system. The permanent magnet motor system includes a shaft for having multiple permanent magnets mounted thereon, and with the shaft rotatably mounted for rotation about a central axis thereof. The permanent magnets are mounted along a predetermined length of the shaft, substantially around the circumference thereof, for causing the shaft to rotate as a result of an inductive force being applied to the permanent magnets. At least three windings, each electrically isolated from each other, are arranged around the permanent magnets, each for being individually electrically excited to generate an induction field. The field generated causes the shaft to rotate as a result of the interaction between the generated field and the permanent magnets. Individual winding controllers, for example, pulse width modulation controller chips, individually control each of the windings in a manner such that should there be a short in one of the windings, the other two windings continue to generate the necessary fields to (1) continue to drive the shaft in a rotational motion, and (2) overcome the drag created by the shorted winding. Thus, the motor system is fault tolerant taking into account, in a DC brushless motor arrangement, the possible shorting of a winding thereof.
The windings are preferably arranged in a Y-winding configuration with each of the winding legs parallel to the others. Such a configuration is conventional and well known to those of ordinary skill in the art. Preferably, the winding controllers are insulated gate bipolar transistor power modules. In a preferred arrangement, the windings comprise at least three windings and more preferably, at least eight. As may
be appreciated, in the case with eight windings, should one winding short, the motor will still retain 3/4 of its power due to the loss of one winding by shorting, and another winding being dedicated to overcoming the drag of the winding that shorted. In the case of a single winding shorting in a three winding arrangement, 1/3 power is retained. In a more specific aspect of the invention, a sensor or sensors are arranged for detecting the rotational position of the shaft. The sensor or sensors provide a signal to a motor controller, which controls the insulated gate bipolar transistor power modules of the windings, to issue a control signal to the power modules to excite the windings to cause the shaft to be rotated into a desired position. These and other features and advantages of the invention will be more readily apparent upon reading the following detailed description of the invention, made with reference to the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a schematic diagram of the control circuit architecture and winding arrangement for a DC brushless motor system in accordance with the invention; and
Figure 2 is a second schematic diagram showing the control modules of Figure 1 connected to a motor controller, and with the motor shaft having a position sensor thereon.
DETAILED DISCUSSION
Referring to Figure 1 , the fault tolerant winding control system, in accordance with the invention, is designated generally by the reference number 1 1. A single common shaft 13 is shown illustrated in association with redundant windings 17 arranged in a Y configuration about the shaft. The shaft 13 includes permanent magnets
15 mounted about the length thereof and about the circumference of the shaft 13. The windings 17 are connected in a manner to be individually and separately electrically excited to generate a field which interacts with the magnets to cause the shaft 13 to rotate. Each winding 17 has three legs, 19a, 19b, and 19c, which are arranged in a conventional and well known Y configuration.
In Figure 1, each winding 17 is shown individually controlled by a respective control module 21. These modules 21 are, for example, insulated gate bipolar transistor power modules. Thus, should a winding 17 be shorted, the other redundant windings 17, which are each individually and separately controlled by the power modules 21 through insulated gate bipolar transistors 23a, 23b and 23c, continue to drive the shaft 13 of the motor.
As may be appreciated, in order to achieve fault tolerant operation, there should be at least three windings 17, and preferably eight (as generally designated by the solid
arrow showing an extension of shaft 13). Thus, the loss of one winding 17 due to shorting, in the case of three, results in a motor having at least 1/3 of its original drive power, and in the case of eight windings, a loss of only 1 /4 of its power.
With respect to the modules 21, they are conventional and well known to those of ordinary skill in the art. Examples of such commercially available modules include the PWR-82331 high current three-phase bridge power hybrid. Details of such a module are disclosed in the publication by ILC Data Device Corporation PWR-282331 Smart Power Three-Phase Bridge. 1989, which disclosure is incorporated by reference herein. To control the power modules 21 such that they are synchronized to ensure that the magnets are acted upon by the fields generated by individual windings 17 in a synchronized manner, a motor controller 27 is employed. Such a controller 27 is conventional and well known and can take the form of, for example, a programmable logic array (PLA). As shown in Figure 2, to ensure more precise operation of the motor, position sensors 29 can be mounted on the shaft 13 to detect the position of the shaft 13 relative to where it has been commanded by motor controller 27 to be located. In such a case, the position detection sensors 29 provide a position signal to motor controller 27 wherein it is compared to a reference to result in an error signal. The error signal is then processed by the controller 27 to generate a signal to the control modules 21 to cause the shaft 19 to be rotated to the desired position correcting for the error until the error signal generated is equal to null.
Modification and variations of the present invention are possible in light of the above teachings. It is therefore understood that within the scope of the appended claims, the invention may be practiced other than as specifically described.
Claims
1. A brushless DC motor system, comprising: a single shaft rotatably mounted for rotation about a central axis thereof; a plurality of permanent magnets mounted along a length of and substantially about the circumference of said single shaft; at least three individually electrically excitable windings, said at least three windings for generating an induction field for interaction with said plurality of permanent magnets to cause said single shaft to rotate about said central axis, each winding individually electrically isolated from the other windings; and at least three synchronized individual control means, each individual control means connected to a corresponding winding of said at least three individually electrically excitable windings, said at least three synchronized individual control means for synchronized individual control of said corresponding windings such that each corresponding winding generates an induction field in a synchronized manner.
2. A system according to claim 1, wherein each of said at least three individually electrically excitable windings are arranged in a y configuration, and wherein each of said at least three synchronized individual control means include at least three insulated gate bipolar transistor power modules.
3. A system according to claim 1, wherein said at least three individually electrically excitable windings include eight sets of windings, each set arranged in a y configuration, and wherein said at least three synchronized control means includes eight insulated gate bipolar transistor power modules.
4. A system according to claim 1 , further comprising: position detecting means for detecting the rotational position of said single shaft and generating a signal indicative of said rotational position; and motor controller means for receiving said signal indicative of said rotational position and for generating a control signal to said at least three synchronized individual control means for exciting said at least three windings to cause said single shaft to rotate to a desired rotational position.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99224292A | 1992-12-14 | 1992-12-14 | |
US992242 | 1992-12-14 | ||
PCT/US1993/011956 WO1994014226A1 (en) | 1992-12-14 | 1993-12-09 | Motor system with individually controlled redundant windings |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0673559A1 true EP0673559A1 (en) | 1995-09-27 |
Family
ID=25538089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP94903543A Withdrawn EP0673559A1 (en) | 1992-12-14 | 1993-12-09 | Motor system with individually controlled redundant windings |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0673559A1 (en) |
JP (1) | JPH08504559A (en) |
RU (1) | RU95114435A (en) |
WO (1) | WO1994014226A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108945485A (en) * | 2017-05-17 | 2018-12-07 | 通用电气公司 | Propulsion system for aircraft |
Families Citing this family (183)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5929549A (en) * | 1998-04-02 | 1999-07-27 | Pacific Scientific Company | Fault tolerant electric machine |
US6437529B1 (en) | 1998-05-04 | 2002-08-20 | Comair Rotron, Inc. | Multi-stator motor with independent stator circuits |
DE19856647B4 (en) * | 1998-12-09 | 2007-03-01 | Canders, Wolf-R., Prof. Dr.-Ing. | Electric high-torque motor |
EP1262687B1 (en) * | 2001-06-01 | 2009-03-25 | IHI Aerospace Co., Ltd. | Electromotive actuator and method for controlling the same |
EP1296443B1 (en) * | 2001-09-19 | 2006-10-04 | Parker Hannifin Corporation | Motor driver and system |
US6700266B2 (en) * | 2002-01-02 | 2004-03-02 | Intel Corporation | Multiple fault redundant motor |
US6791209B2 (en) | 2002-01-02 | 2004-09-14 | Intel Corporation | Power and control for power supply fans |
US6724183B2 (en) | 2002-01-02 | 2004-04-20 | Intel Corporation | Method and apparatus for detecting bearing failure |
US6819017B2 (en) | 2002-01-02 | 2004-11-16 | Intel Corporation | Method and apparatus for fan redundancy |
EP2023939B1 (en) | 2006-05-05 | 2012-06-27 | Isis Pharmaceuticals, Inc. | Compounds and methods for modulating expression of pcsk9 |
EP2505648A1 (en) | 2006-05-05 | 2012-10-03 | Isis Pharmaceuticals, Inc. | Compounds and methods for modulating expression of PTP1B |
US7443642B2 (en) | 2006-05-26 | 2008-10-28 | Pratt & Whitney Canada Corp. | Electric motor control |
GB0613941D0 (en) | 2006-07-13 | 2006-08-23 | Pml Flightlink Ltd | Electronically controlled motors |
ATE540118T1 (en) | 2006-10-18 | 2012-01-15 | Isis Pharmaceuticals Inc | ANTISENSE COMPOUNDS |
US7541705B2 (en) | 2007-03-28 | 2009-06-02 | General Electric Company | Fault-tolerant permanent magnet machine with reconfigurable flux paths in stator back iron |
US7605504B2 (en) | 2007-03-28 | 2009-10-20 | General Electric Company | Fault-tolerant permanent magnet machine with reconfigurable stator core slot flux paths |
US7605503B2 (en) | 2007-03-28 | 2009-10-20 | General Electric Company | Fault-tolerant permanent magnet machine with reconfigurable stator core slot opening and back iron flux paths |
DE102007048642A1 (en) * | 2007-10-10 | 2009-04-16 | Mtu Aero Engines Gmbh | Electric drive, in particular for a fuel metering unit for an aircraft engine |
US7786684B2 (en) * | 2007-10-22 | 2010-08-31 | Honeywell International Inc. | Electromechanical flight control system and method for rotorcraft |
US8222221B2 (en) | 2008-06-04 | 2012-07-17 | The Board Of Regents Of The University Of Texas System | Modulation of gene expression through endogenous small RNA targeting of gene promoters |
US8901095B2 (en) | 2008-07-29 | 2014-12-02 | The Board Of Regents Of The University Of Texas System | Selective inhibition of polyglutamine protein expression |
EP2447274B1 (en) | 2008-10-24 | 2017-10-04 | Ionis Pharmaceuticals, Inc. | Oligomeric compounds and methods |
US8476798B2 (en) | 2008-11-28 | 2013-07-02 | Pratt & Whitney Canada Corp. | Tandem electric machine arrangement |
WO2010091308A2 (en) | 2009-02-06 | 2010-08-12 | Isis Pharmaceuticals, Inc. | Oligomeric compounds and methods |
WO2010124231A2 (en) | 2009-04-24 | 2010-10-28 | The Board Of Regents Of The University Of Texas System | Modulation of gene expression using oligomers that target gene regions downstream of 3' untranslated regions |
US8749192B2 (en) | 2009-09-03 | 2014-06-10 | Protean Electric Limited | Electric motor and electric generator |
GB2462940B8 (en) * | 2009-09-03 | 2012-03-28 | Protean Holdings Corp | Electric motor and electric generator. |
US20110110860A1 (en) | 2009-11-02 | 2011-05-12 | The Board Of Regents Of The University Of Texas System | Modulation of ldl receptor gene expression with double-stranded rnas targeting the ldl receptor gene promoter |
EP2521556B1 (en) | 2010-01-08 | 2018-05-30 | Ionis Pharmaceuticals, Inc. | Modulation of angiopoietin-like 3 expression |
US9574191B2 (en) | 2010-02-03 | 2017-02-21 | The Board Of Regents Of The University Of Texas System | Selective inhibition of polyglutamine protein expression |
CA2789005A1 (en) | 2010-02-08 | 2011-08-11 | Isis Pharmaceuticals, Inc. | Selective reduction of allelic variants |
EP3628750A1 (en) | 2010-02-08 | 2020-04-01 | Ionis Pharmaceuticals, Inc. | Selective reduction of allelic variants |
CN103154014B (en) | 2010-04-28 | 2015-03-25 | Isis制药公司 | Modified nucleosides, modified nucleosides-like and oligomeric compounds prepared therefrom |
US9127033B2 (en) | 2010-04-28 | 2015-09-08 | Isis Pharmaceuticals, Inc. | 5′ modified nucleosides and oligomeric compounds prepared therefrom |
EP2606057B1 (en) | 2010-04-28 | 2016-06-15 | Ionis Pharmaceuticals, Inc. | Modified 5' diphosphate nucleosides and oligomeric compounds prepared therefrom |
US20130156845A1 (en) | 2010-04-29 | 2013-06-20 | Alnylam Pharmaceuticals, Inc. | Lipid formulated single stranded rna |
SI2563920T1 (en) | 2010-04-29 | 2017-05-31 | Ionis Pharmaceuticals, Inc. | Modulation of transthyretin expression |
US8957200B2 (en) | 2010-06-07 | 2015-02-17 | Isis Pharmaceuticals, Inc. | Bicyclic nucleosides and oligomeric compounds prepared therefrom |
EP2580228B1 (en) | 2010-06-08 | 2016-03-23 | Ionis Pharmaceuticals, Inc. | Substituted 2'-amino and 2'-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom |
US20130237585A1 (en) | 2010-07-19 | 2013-09-12 | University Of Rochester | Modulation of dystrophia myotonica-protein kinase (dmpk) expression |
JP5577506B2 (en) | 2010-09-14 | 2014-08-27 | ソーラテック コーポレイション | Centrifugal pump device |
FR2967310B1 (en) | 2010-11-04 | 2013-08-02 | Xap | ELECTROMAGNETIC MOTOR WITHOUT BRUSH |
CA3077910A1 (en) | 2010-11-17 | 2012-05-24 | Ionis Pharmaceuticals, Inc. | Modulation of alpha synuclein expression |
EP3467109A1 (en) | 2011-02-08 | 2019-04-10 | Ionis Pharmaceuticals, Inc. | Oligomeric compounds comprising bicyclic nucleotides and uses thereof |
JP5969979B2 (en) | 2011-03-28 | 2016-08-17 | ソーラテック コーポレイション | Rotation drive device and centrifugal pump device using the same |
KR20190092590A (en) | 2011-04-01 | 2019-08-07 | 아이오니스 파마수티컬즈, 인코포레이티드 | Modulation of signal transducer and activator of transcription 3 (stat3) expression |
DE102011016336A1 (en) | 2011-04-07 | 2012-10-11 | Airbus Operations Gmbh | High-lift system for an aircraft |
WO2012142458A1 (en) | 2011-04-13 | 2012-10-18 | Isis Pharmaceuticals, Inc. | Antisense modulation of ptp1b expression |
DK3505528T3 (en) | 2011-04-21 | 2021-02-08 | Ionis Pharmaceuticals Inc | MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSION |
US9157082B2 (en) | 2011-04-27 | 2015-10-13 | Isis Pharmaceuticals, Inc. | Modulation of apolipoprotein CIII (ApoCIII) expression |
WO2012170347A1 (en) | 2011-06-09 | 2012-12-13 | Isis Pharmaceuticals, Inc. | Bicyclic nucleosides and oligomeric compounds prepared therefrom |
WO2012170945A2 (en) | 2011-06-10 | 2012-12-13 | Isis Pharmaceuticals, Inc. | Methods for modulating kallikrein (klkb1) expression |
EP2721156B1 (en) | 2011-06-16 | 2016-12-21 | Ionis Pharmaceuticals, Inc. | Antisense modulation of fibroblast growth factor receptor 4 expression |
CA2840614A1 (en) | 2011-06-29 | 2013-01-03 | Isis Pharmaceuticals, Inc. | Methods for modulating kallikrein (klkb1) expression |
EP2742135B2 (en) | 2011-08-11 | 2020-06-10 | Ionis Pharmaceuticals, Inc. | Linkage modified gapped oligomeric compounds and uses thereof |
WO2013033230A1 (en) | 2011-08-29 | 2013-03-07 | Isis Pharmaceuticals, Inc. | Oligomer-conjugate complexes and their use |
EP2758533B1 (en) | 2011-09-20 | 2018-04-11 | Ionis Pharmaceuticals, Inc. | Antisense modulation of gcgr expression |
IN2014CN03749A (en) | 2011-10-25 | 2015-09-25 | Isis Pharmaceuticals Inc | |
WO2013070786A1 (en) | 2011-11-07 | 2013-05-16 | Isis Pharmaceuticals, Inc. | Modulation of tmprss6 expression |
WO2013096837A1 (en) | 2011-12-22 | 2013-06-27 | Isis Pharmaceuticals, Inc. | Methods for modulating metastasis-associated-in-lung-adenocarcinoma-transcript-1(malat-1) expression |
US20150025231A1 (en) | 2012-01-11 | 2015-01-22 | Cold Spring Harbor Laboratory | Compositions and methods for modulation of ikbkap splicing |
WO2013120003A1 (en) | 2012-02-08 | 2013-08-15 | Isis Pharmaceuticals, Inc. | Modulation of rna by repeat targeting |
US8837096B2 (en) | 2012-03-13 | 2014-09-16 | Thoratec Corporation | Fault monitor for fault tolerant implantable pump |
EP2850092B1 (en) | 2012-04-09 | 2017-03-01 | Ionis Pharmaceuticals, Inc. | Tricyclic nucleic acid analogs |
WO2013154799A1 (en) | 2012-04-09 | 2013-10-17 | Isis Pharmaceuticals, Inc. | Tricyclic nucleosides and oligomeric compounds prepared therefrom |
EP2839006B1 (en) | 2012-04-20 | 2018-01-03 | Ionis Pharmaceuticals, Inc. | Oligomeric compounds comprising bicyclic nucleotides and uses thereof |
WO2013177248A2 (en) | 2012-05-22 | 2013-11-28 | Isis Pharmaceuticals, Inc. | Modulation of enhancer rna mediated gene expression |
ES2820548T3 (en) | 2012-05-24 | 2021-04-21 | Ionis Pharmaceuticals Inc | Methods and compositions to modulate the expression of apolipoprotein (a) |
LT3461895T (en) | 2012-06-25 | 2020-09-10 | Ionis Pharmaceuticals, Inc. | Modulation of ube3a-ats expression |
US20150297629A1 (en) | 2012-07-27 | 2015-10-22 | Isis Pharmaceuticals, Inc. | Modulation of renin-angiotensin system (ras) related diseases by angiotensinogen |
EP2897633B1 (en) | 2012-09-18 | 2020-01-01 | UTI Limited Partnership | Treatment of pain by inhibition of usp5 de-ubiquitinase |
US9175291B2 (en) | 2012-10-11 | 2015-11-03 | Isis Pharmaceuticals Inc. | Modulation of androgen receptor expression |
WO2014059364A1 (en) | 2012-10-11 | 2014-04-17 | Isis Pharmaceuticals, Inc. | Methods of treating kennedy's disease |
EP4144845B1 (en) | 2012-10-12 | 2024-04-24 | Ionis Pharmaceuticals, Inc. | Antisense compounds and uses thereof |
WO2014059356A2 (en) | 2012-10-12 | 2014-04-17 | Isis Pharmaceuticals, Inc. | Selective antisense compounds and uses thereof |
US9963699B2 (en) | 2012-10-15 | 2018-05-08 | Ionis Pharmaceuticals, Inc. | Methods for modulating C9ORF72 expression |
RS58576B1 (en) | 2012-10-31 | 2019-05-31 | Ionis Pharmaceuticals Inc | Cancer treatment |
RU2015119411A (en) | 2012-11-15 | 2017-01-10 | Рош Инновейшен Сентер Копенгаген А/С | ANTI-SENSE COMPOUNDS CONJUGATES AIMED AT APOLIPOPROTEIN IN |
KR20150088305A (en) | 2012-11-26 | 2015-07-31 | 로슈 이노베이션 센터 코펜하겐 에이/에스 | Compositions and methods for modulation of fgfr3 expression |
US8968174B2 (en) | 2013-01-16 | 2015-03-03 | Thoratec Corporation | Motor fault monitor for implantable blood pump |
US9371826B2 (en) | 2013-01-24 | 2016-06-21 | Thoratec Corporation | Impeller position compensation using field oriented control |
MY177989A (en) | 2013-01-30 | 2020-09-28 | Hoffmann La Roche | Lna oligonucleotide carbohydrate conjugates |
WO2014118272A1 (en) | 2013-01-30 | 2014-08-07 | Santaris Pharma A/S | Antimir-122 oligonucleotide carbohydrate conjugates |
US10260069B2 (en) | 2013-02-04 | 2019-04-16 | Ionis Pharmaceuticals, Inc. | Selective antisense compounds and uses thereof |
KR102169899B1 (en) | 2013-02-14 | 2020-10-26 | 아이오니스 파마수티컬즈, 인코포레이티드 | Modulation of apolipoprotein c-iii (apociii) expression in lipoprotein lipase deficient (lpld) populations |
US9556873B2 (en) | 2013-02-27 | 2017-01-31 | Tc1 Llc | Startup sequence for centrifugal pump with levitated impeller |
US10398661B2 (en) | 2013-02-28 | 2019-09-03 | The Board Of Regents Of The University Of Texas System | Methods for classifying a cancer as susceptible to TMEPAI-directed therapies and treating such cancers |
DE102013102194A1 (en) * | 2013-03-06 | 2014-09-11 | Werner Eck | Drive device for a moving in a fluid vehicle |
BR112015022156A2 (en) | 2013-03-14 | 2017-11-14 | Isis Pharmaceuticals Inc | compositions and methods for modulating tau expression |
US10052420B2 (en) | 2013-04-30 | 2018-08-21 | Tc1 Llc | Heart beat identification and pump speed synchronization |
US9127276B2 (en) | 2013-05-01 | 2015-09-08 | Isis Pharmaceuticals, Inc. | Conjugated antisense compounds and their use |
EP3656386A1 (en) | 2013-06-21 | 2020-05-27 | Ionis Pharmaceuticals, Inc. | Compounds and methods for modulating apolipoprotein c-iii expression for improving a diabetic profile |
EP3011028B1 (en) | 2013-06-21 | 2019-06-12 | Ionis Pharmaceuticals, Inc. | Compositions and methods for modulation of target nucleic acids |
BR112015032432B1 (en) | 2013-06-27 | 2023-02-07 | Roche Innovation Center Copenhagen A/S | ANTI-SENSE OLIGOMER, ANTI-SENSE OLIGONUCLEOTIDE CONJUGATES, PHARMACEUTICAL COMPOSITION, USE THEREOF FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA OR RELATED DISORDERS, AND IN VITRO METHOD FOR REDUCING THE EXPRESSION LEVELS AND/OR THE ACTIVITY OF PCSK9 IN A CELL |
WO2015002971A2 (en) | 2013-07-02 | 2015-01-08 | Isis Pharmaceuticals, Inc. | Modulators of growth hormone receptor |
TWI657819B (en) | 2013-07-19 | 2019-05-01 | 美商Ionis製藥公司 | Compositions for modulating tau expression |
EP4079745A1 (en) | 2013-08-08 | 2022-10-26 | The Scripps Research Institute | A method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides |
TW201536329A (en) | 2013-08-09 | 2015-10-01 | Isis Pharmaceuticals Inc | Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expression |
CA2921839A1 (en) | 2013-08-28 | 2015-03-05 | Ionis Pharmaceuticals, Inc. | Modulation of prekallikrein (pkk) expression |
PL3043827T3 (en) | 2013-09-13 | 2020-03-31 | Ionis Pharmaceuticals, Inc. | Modulators of complement factor b |
US9943604B2 (en) | 2013-09-20 | 2018-04-17 | Ionis Pharmaceuticals, Inc. | Targeted therapeutic nucleosides and their use |
WO2015054676A2 (en) | 2013-10-11 | 2015-04-16 | Isis Pharmaceuticals, Inc. | Compositions for modulating c9orf72 expression |
US9239345B2 (en) | 2013-11-20 | 2016-01-19 | Woodward, Inc. | Controlling a motor with two or more Hall sensors |
EP3750997A1 (en) | 2013-12-02 | 2020-12-16 | Ionis Pharmaceuticals, Inc. | Antisense compounds and uses thereof |
CN111394355A (en) | 2013-12-24 | 2020-07-10 | Ionis制药公司 | Modulation of angiopoietin-like 3 expression |
US10988030B2 (en) | 2014-09-26 | 2021-04-27 | Francis Xavier Gentile | Electric motor, generator and battery combination |
CN106103717A (en) | 2014-03-19 | 2016-11-09 | Ionis制药公司 | For regulating the compositions that ataxin 2 is expressed |
SG11201608109TA (en) | 2014-04-01 | 2016-10-28 | Ionis Pharmaceuticals Inc | Compositions for modulating sod-1 expression |
EP3129493B1 (en) | 2014-04-09 | 2021-07-07 | The Scripps Research Institute | Import of unnatural or modified nucleoside triphosphates into cells via nucleic acid triphosphate transporters |
WO2015164693A1 (en) | 2014-04-24 | 2015-10-29 | Isis Pharmaceuticals, Inc. | Oligomeric compounds comprising alpha-beta-constrained nucleic acid |
WO2015168172A1 (en) | 2014-04-28 | 2015-11-05 | Isis Pharmaceuticals, Inc. | Linkage modified oligomeric compounds |
WO2015168514A1 (en) | 2014-05-01 | 2015-11-05 | Isis Pharmaceuticals, Inc. | Method for synthesis of reactive conjugate clusters |
HUE052709T2 (en) | 2014-05-01 | 2021-05-28 | Ionis Pharmaceuticals Inc | Conjugates of modified antisense oligonucleotides and their use for modulating pkk expression |
US10570169B2 (en) | 2014-05-22 | 2020-02-25 | Ionis Pharmaceuticals, Inc. | Conjugated antisense compounds and their use |
US9623161B2 (en) | 2014-08-26 | 2017-04-18 | Tc1 Llc | Blood pump and method of suction detection |
US10364433B2 (en) | 2014-11-14 | 2019-07-30 | The Regents Of The University Of California | Modulation of AGPAT5 expression |
CN105634225B (en) * | 2014-11-26 | 2020-10-09 | 德昌电机(深圳)有限公司 | Brushless DC motor and electric power steering system using the same |
US9517270B2 (en) | 2014-12-08 | 2016-12-13 | The Board Of Regents Of The University Of Texas System | Lipocationic polymers and uses thereof |
WO2016100716A1 (en) | 2014-12-18 | 2016-06-23 | Vasant Jadhav | Reversirtm compounds |
CN104617827B (en) * | 2015-02-02 | 2017-05-31 | 东南大学 | A kind of axial magnetic field flux switch permanent magnet motor fault tolerant control method used for electric vehicle |
WO2016130846A1 (en) | 2015-02-11 | 2016-08-18 | Thoratec Corporation | Heart beat identification and pump speed synchronization |
US10371152B2 (en) | 2015-02-12 | 2019-08-06 | Tc1 Llc | Alternating pump gaps |
WO2016130944A1 (en) | 2015-02-12 | 2016-08-18 | Thoratec Corporation | System and method for controlling the position of a levitated rotor |
EP3626277A1 (en) | 2015-02-13 | 2020-03-25 | Tc1 Llc | Impeller suspension mechanism for heart pump |
MX2017011010A (en) | 2015-02-26 | 2017-10-20 | Ionis Pharmaceuticals Inc | Allele specific modulators of p23h rhodopsin. |
DK3265564T3 (en) | 2015-03-03 | 2022-04-11 | Ionis Pharmaceuticals Inc | METHOD FOR MODULING MECP2 EXPRESSION |
WO2016141236A1 (en) | 2015-03-03 | 2016-09-09 | Ionis Pharmaceuticals, Inc. | Compositions for modulating mecp2 expression |
US11414657B2 (en) | 2015-06-29 | 2022-08-16 | Ionis Pharmaceuticals, Inc. | Modified CRISPR RNA and modified single CRISPR RNA and uses thereof |
WO2017011276A1 (en) | 2015-07-10 | 2017-01-19 | Ionis Pharmaceuticals, Inc. | Modulators of diacyglycerol acyltransferase 2 (dgat2) |
JP2018520683A (en) | 2015-07-17 | 2018-08-02 | アルニラム ファーマスーティカルズ インコーポレイテッドAlnylam Pharmaceuticals, Inc. | Multi-target single-body conjugates |
JP7041616B2 (en) | 2015-09-14 | 2022-03-24 | ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム | Lipocationic dendrimer and its use |
RU2018113709A (en) | 2015-09-24 | 2019-10-30 | Айонис Фармасьютикалз, Инк. | KRAS EXPRESSION MODULATORS |
US10117983B2 (en) | 2015-11-16 | 2018-11-06 | Tc1 Llc | Pressure/flow characteristic modification of a centrifugal pump in a ventricular assist device |
US11761007B2 (en) | 2015-12-18 | 2023-09-19 | The Scripps Research Institute | Production of unnatural nucleotides using a CRISPR/Cas9 system |
WO2017201076A1 (en) | 2016-05-16 | 2017-11-23 | The Board Of Regents Of The University Of Texas System | Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids |
ES2929047T3 (en) | 2016-06-24 | 2022-11-24 | Scripps Research Inst | Novel nucleoside triphosphate transporter and uses thereof |
US10479223B2 (en) | 2018-01-25 | 2019-11-19 | H55 Sa | Construction and operation of electric or hybrid aircraft |
US11148819B2 (en) | 2019-01-23 | 2021-10-19 | H55 Sa | Battery module for electrically-driven aircraft |
US11065979B1 (en) | 2017-04-05 | 2021-07-20 | H55 Sa | Aircraft monitoring system and method for electric or hybrid aircrafts |
US10854866B2 (en) | 2019-04-08 | 2020-12-01 | H55 Sa | Power supply storage and fire management in electrically-driven aircraft |
US11063323B2 (en) | 2019-01-23 | 2021-07-13 | H55 Sa | Battery module for electrically-driven aircraft |
SG11202000939PA (en) | 2017-08-03 | 2020-02-27 | Synthorx Inc | Cytokine conjugates for the treatment of proliferative and infectious diseases |
SG11202007728QA (en) | 2018-02-26 | 2020-09-29 | Synthorx Inc | Il-15 conjugates and uses thereof |
TW202016301A (en) | 2018-05-07 | 2020-05-01 | 美商阿里拉姆製藥股份有限公司 | Extrahepatic delivery |
TW202028465A (en) | 2018-09-28 | 2020-08-01 | 美商阿尼拉製藥公司 | Transthyretin (ttr) irna compositions and methods of use thereof for treating or preventing ttr-associated ocular diseases |
KR20210123299A (en) | 2019-02-06 | 2021-10-13 | 신톡스, 인크. | IL-2 conjugates and methods of use thereof |
US20220228140A1 (en) | 2019-03-29 | 2022-07-21 | Mitsubishi Tanabe Pharma Corporation | Compound, method and pharmaceutical composition for modulating expression of dux4 |
CA3138915A1 (en) | 2019-05-17 | 2020-11-26 | Alnylam Pharmaceuticals, Inc. | Oral delivery of oligonucleotides |
KR20220047598A (en) | 2019-08-15 | 2022-04-18 | 신톡스, 인크. | Immuno-oncology Combination Therapy Using IL-2 Conjugates |
US20210054040A1 (en) | 2019-08-23 | 2021-02-25 | Synthorx, Inc. | Novel il-15 conjugates and uses thereof |
KR20220061158A (en) | 2019-09-10 | 2022-05-12 | 신톡스, 인크. | IL-2 conjugates and methods of use for treating autoimmune diseases |
JP2022554272A (en) | 2019-11-04 | 2022-12-28 | シンソークス, インコーポレイテッド | Interleukin 10 conjugates and uses thereof |
KR20220110749A (en) | 2019-11-06 | 2022-08-09 | 알닐람 파마슈티칼스 인코포레이티드 | extrahepatic transmission |
WO2021092145A1 (en) | 2019-11-06 | 2021-05-14 | Alnylam Pharmaceuticals, Inc. | Transthyretin (ttr) irna composition and methods of use thereof for treating or preventing ttr-associated ocular diseases |
US20230227824A1 (en) | 2020-05-12 | 2023-07-20 | Mitsubishi Tanabe Pharma Corporation | Compound, method and pharmaceutical composition for regulating expression of ataxin 3 |
AU2021296622A1 (en) | 2020-06-25 | 2023-02-23 | Synthorx, Inc. | Immuno oncology combination therapy with IL-2 conjugates and anti-EGFR antibodies |
WO2022011214A1 (en) | 2020-07-10 | 2022-01-13 | Alnylam Pharmaceuticals, Inc. | Circular sirnas |
BR112023006364A2 (en) | 2020-10-09 | 2023-05-09 | Synthorx Inc | IMMUNO-ONCOLOGY COMBINATION THERAPY WITH IL-2 AND PEMBROLIZUMAB CONJUGATES |
KR20230084204A (en) | 2020-10-09 | 2023-06-12 | 신톡스, 인크. | Immuno-oncology therapy using IL-2 conjugates |
WO2022147214A2 (en) | 2020-12-31 | 2022-07-07 | Alnylam Pharmaceuticals, Inc. | Cyclic-disulfide modified phosphate based oligonucleotide prodrugs |
WO2022147223A2 (en) | 2020-12-31 | 2022-07-07 | Alnylam Pharmaceuticals, Inc. | 2'-modified nucleoside based oligonucleotide prodrugs |
EP4291243A1 (en) | 2021-02-12 | 2023-12-20 | Synthorx, Inc. | Lung cancer combination therapy with il-2 conjugates and an anti-pd-1 antibody or antigen-binding fragment thereof |
WO2022174101A1 (en) | 2021-02-12 | 2022-08-18 | Synthorx, Inc. | Skin cancer combination therapy with il-2 conjugates and cemiplimab |
AU2022249318A1 (en) | 2021-03-31 | 2023-10-12 | Entrada Therapeutics, Inc. | Cyclic cell penetrating peptides |
AU2022271873A1 (en) | 2021-05-10 | 2024-01-04 | Entrada Therapeutics, Inc. | Compositions and methods for intracellular therapeutics |
EP4337263A1 (en) | 2021-05-10 | 2024-03-20 | Entrada Therapeutics, Inc. | Compositions and methods for modulating interferon regulatory factor-5 (irf-5) activity |
EP4337261A2 (en) | 2021-05-10 | 2024-03-20 | Entrada Therapeutics, Inc. | Compositions and methods for modulating mrna splicing |
US11682997B2 (en) | 2021-05-17 | 2023-06-20 | Hitachi Astemo Americas, Inc. | Rotary electric machine with selectable coil control |
TW202313117A (en) | 2021-06-03 | 2023-04-01 | 美商欣爍克斯公司 | Head and neck cancer combination therapy comprising an il-2 conjugate and cetuximab |
WO2022271818A1 (en) | 2021-06-23 | 2022-12-29 | Entrada Therapeutics, Inc. | Antisense compounds and methods for targeting cug repeats |
WO2023283403A2 (en) | 2021-07-09 | 2023-01-12 | Alnylam Pharmaceuticals, Inc. | Bis-rnai compounds for cns delivery |
KR20240036041A (en) | 2021-07-21 | 2024-03-19 | 알닐람 파마슈티칼스 인코포레이티드 | Metabolic Disorder-Associated Target Gene iRNA Composition and Methods of Using Same |
IL311139A (en) | 2021-09-01 | 2024-04-01 | Entrada Therapeutics Inc | Compounds and methods for skipping exon 44 in duchenne muscular dystrophy |
CA3234887A1 (en) | 2021-10-15 | 2023-04-20 | Alnylam Pharmaceuticals, Inc. | Extra-hepatic delivery irna compositions and methods of use thereof |
WO2023086292A2 (en) | 2021-11-10 | 2023-05-19 | University Of Rochester | Gata4-targeted therapeutics for treatment of cardiac hypertrophy |
WO2023086295A2 (en) | 2021-11-10 | 2023-05-19 | University Of Rochester | Antisense oligonucleotides for modifying protein expression |
WO2023122573A1 (en) | 2021-12-20 | 2023-06-29 | Synthorx, Inc. | Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumab |
WO2023122750A1 (en) | 2021-12-23 | 2023-06-29 | Synthorx, Inc. | Cancer combination therapy with il-2 conjugates and cetuximab |
WO2023220744A2 (en) | 2022-05-13 | 2023-11-16 | Alnylam Pharmaceuticals, Inc. | Single-stranded loop oligonucleotides |
WO2024006999A2 (en) | 2022-06-30 | 2024-01-04 | Alnylam Pharmaceuticals, Inc. | Cyclic-disulfide modified phosphate based oligonucleotide prodrugs |
WO2024039776A2 (en) | 2022-08-18 | 2024-02-22 | Alnylam Pharmaceuticals, Inc. | Universal non-targeting sirna compositions and methods of use thereof |
WO2024050261A1 (en) | 2022-08-29 | 2024-03-07 | University Of Rochester | Antisense oligonucleotide-based anti-fibrotic therapeutics |
WO2024073732A1 (en) | 2022-09-30 | 2024-04-04 | Alnylam Pharmaceuticals, Inc. | Modified double-stranded rna agents |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3809990A (en) * | 1972-07-27 | 1974-05-07 | Warner Electric Brake & Clutch | Electric motor adapted for both stepping and continuous operation |
US4434389A (en) * | 1980-10-28 | 1984-02-28 | Kollmorgen Technologies Corporation | Motor with redundant windings |
FR2541529A1 (en) * | 1983-02-18 | 1984-08-24 | Sundstrand Corp | MULTI-CHANNEL ELECTROMOTOR MACHINE |
-
1993
- 1993-12-09 EP EP94903543A patent/EP0673559A1/en not_active Withdrawn
- 1993-12-09 RU RU95114435/07A patent/RU95114435A/en unknown
- 1993-12-09 JP JP6514388A patent/JPH08504559A/en active Pending
- 1993-12-09 WO PCT/US1993/011956 patent/WO1994014226A1/en not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
See references of WO9414226A1 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108945485A (en) * | 2017-05-17 | 2018-12-07 | 通用电气公司 | Propulsion system for aircraft |
Also Published As
Publication number | Publication date |
---|---|
RU95114435A (en) | 1997-05-20 |
JPH08504559A (en) | 1996-05-14 |
WO1994014226A1 (en) | 1994-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1994014226A1 (en) | Motor system with individually controlled redundant windings | |
US5990643A (en) | Sensorless commutation position detection for brushless D.C. motors | |
US5912522A (en) | Permanent magnet direct current (PMDC) machine with integral reconfigurable winding control | |
US8084972B2 (en) | Dual lane control of a permanent magnet brushless motor using non-trapezoidal commutation control | |
AU2004208342A1 (en) | Phase advance angle optimization for brushless motor control | |
US4565956A (en) | Fast-acting servo drive system | |
JP2001157487A (en) | Controller for electric rotating machine | |
WO1992020135A1 (en) | Torque driven dual pmg actuator | |
US5113824A (en) | Adjusting device | |
US4401931A (en) | Apparatus actuated by a pair of stepper motors with shared drive | |
US4963800A (en) | Apparatus for controlling throttle actuator | |
US6646851B1 (en) | Circuit arrangement for operating a solenoid actuator | |
CN105703590A (en) | reluctance motor with virtual rotor | |
Kusko et al. | Definition of the brushless DC motor | |
EP3346600A1 (en) | High efficiency actuator for use in a mometum control device | |
US6573672B2 (en) | Fail passive servo controller | |
US6953013B2 (en) | Valve timing controller | |
EP1429449B1 (en) | Torque stabilizer for brushless servo motor | |
Awaar et al. | Comparative Study And Experimentation of Speed Control Methods of BLDC Motor using DRV8312 | |
WO2008103630A1 (en) | Adjusting commutation of a brusheless dc motor to increase motor speed | |
US5783920A (en) | Error signal control circuit for a phase-lock-loop sensorless motor controller | |
US5247217A (en) | Safety system for a stepper-motor drive | |
US20030201677A1 (en) | Step motor with multiple stators | |
JP2004521598A (en) | Switched reluctance motor with radial and transversal magnetic flux | |
JP2000116097A (en) | Motor equipment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19950523 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): DE FR GB IT |
|
17Q | First examination report despatched |
Effective date: 19951107 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Withdrawal date: 19960301 |